Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Opus Genetics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 41 | 1 | 38 | −2 |
| Shares | 2.07M | 26.1K | 2.41M | +364.6K (+17.8%) |
| Value | $6.69M | $84.0K | $4.62M | −$1.99M (−30.0%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Opus Genetics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 198,190 | $381.0K | 0.00% |
| Millennium Management LLC | 35,582 | $68.0K | 0.00% |
| Eidelman Virant Capital | 25,000 | $48.0K | 0.03% |
| Warberg Asset Management LLC | 24,200 | $46.0K | 0.02% |
| Citadel Advisors LLC | 16,458 | $32.0K | 0.00% |
| Charles Schwab Investment Management Inc | 14,928 | $29.0K | 0.00% |
| Kestra Advisory Services, LLC | 10,005 | $19.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,136 | $6.00K | 0.00% |
Sold out (10)
Institutions that held Opus Genetics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ikarian Capital, LLC | 124,021 | $401.0K |
| Two Sigma Investments, LP | 51,700 | $168.0K |
| Bank of Montreal | 15,600 | $68.0K |
| Occudo Quantitative Strategies LP | 18,600 | $60.0K |
| Dimensional Fund Advisors LP | 16,575 | $54.0K |
| Schonfeld Strategic Advisors LLC | 14,000 | $45.0K |
| Powell Investment Advisors, LLC | 13,500 | $44.0K |
| Boothbay Fund Management, LLC | 11,901 | $39.0K |
| Simplex Trading, LLC | 10,243 | $33.0K |
| Citigroup Inc | 66 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 26,055 | $84.0K |